Ono Pharmaceutical (OTCMKTS:OPHLF) Stock Price Passes Above 50-Day Moving Average – Here’s Why

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF) shares passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $10.49 and traded as high as $10.51. Ono Pharmaceutical shares last traded at $10.51, with a volume of 1,647 shares traded.

Ono Pharmaceutical Stock Down 4.5 %

The company has a market cap of $4.94 billion, a P/E ratio of 7.87 and a beta of 0.59. The firm’s 50-day moving average price is $10.49 and its 200-day moving average price is $12.61.

Ono Pharmaceutical (OTCMKTS:OPHLF) last issued its earnings results on Thursday, October 31st. The company reported $0.24 earnings per share (EPS) for the quarter. The business had revenue of $824.42 million for the quarter. Ono Pharmaceutical had a net margin of 19.64% and a return on equity of 11.80%.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.